This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Weight Loss Solutions Offered By Dr. Feiz Affect Patients At A Genetic Level

LOS ANGELES, May 3, 2013 /PRNewswire/ -- Michael Feiz, M.D., FACS is renowned throughout Southern California for performing life-changing weight loss procedures such as FDA compliant lap band surgery. One of the most effective procedures of Dr. Feiz, the sleeve gastrectomy, helps patients lose weight by removing large portions of the fundus, which contains the ghrelin hormone that causes the hunger cravings that often make weight loss so difficult. However, in addition to their success in promoting weight loss, new evidence shows that many of these procedures are leading to other major health benefits as well.

More research will be needed before it is known precisely why gastric bypass surgery has been found to induce early remission of type 2 diabetes in the vast majority of patients, according to a report from the Society for Endocrinology. "We provide evidence that in severely obese people, the levels of specific genes that control how fat is burned and stored in the body are changed to reflect poor metabolic health," says Professor Juleen Zierath, senior author of the study. Zierath continues, "After surgery, the levels of these genes are restored to a healthy state, which mirrors weight loss and coincides with overall improvement in metabolism."

A deeper investigation into the results of the study found that weight loss after surgery actually caused changes at a genetic level, leading to modifications among the DNA that control gene expression in response to the environment. In particular, chemical markings on two genes that control glucose and fat metabolism correlated with obesity are reversed after surgery-induced weight loss. Scientists are already suggesting that the findings may be useful for the design of new drugs that mimic the weight-loss-associated control of gene regulation. For the medical professionals at Dr. Feiz and Associates, this is exciting news.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs